Researchers at The Ottawa Hospital have identified the biological mechanism behind space anemia, a condition where astronauts lose red blood cells at an accelerated rate. The study reveals that microgravity causes the body to destroy 54 percent more cells than it does on Earth, posing challenges for long-term missions to Mars.
TLDR: A team at The Ottawa Hospital has discovered that space travel causes the body to destroy 54% more red blood cells than normal. This process persists throughout missions, requiring new nutritional and medical strategies for future long-duration voyages to the Moon and Mars.
For more than five decades, astronauts returning from space have consistently exhibited signs of anemia, a condition characterized by a deficiency of red blood cells. While scientists initially believed this was a temporary adaptation to the fluid shifts caused by microgravity, new research from The Ottawa Hospital and the University of Ottawa suggests a more permanent and aggressive biological process. The study reveals that the human body destroys significantly more red blood cells in space than it does on Earth, a phenomenon that persists for the entire duration of a mission. This discovery changes the fundamental understanding of how the human vascular system reacts to the absence of gravity.
Led by Dr. Guy Trudel, a rehabilitation physician and researcher at The Ottawa Hospital, the team analyzed the breath and blood samples of 14 astronauts during their six-month missions on the International Space Station. By measuring the amount of carbon monoxide in the breath samples, the researchers were able to calculate the rate of red blood cell destruction. One molecule of carbon monoxide is produced for every molecule of heme that is broken down. On Earth, the human body typically creates and destroys approximately 2 million red blood cells every second. In microgravity, the study found that astronauts were destroying 3 million red blood cells per second, a 54 percent increase.
This accelerated destruction, known as hemolysis, was previously thought to be a short-term response to the initial shift of fluids to the upper body. However, the data showed that the high rate of cell loss continued unabated throughout the six-month observation period. The body appears to enter a state of chronic hemolysis that does not stabilize until the astronaut returns to a gravity-rich environment. This non-invasive technique allowed the hospital team to monitor the astronauts without the need for frequent, large-volume blood draws, which are difficult to manage in orbit.
The implications for long-term space exploration are significant. As NASA and other space agencies plan for multi-year missions to Mars, the health of the crew remains a primary concern. Anemia can lead to fatigue, decreased strength, and impaired cognitive function, all of which could jeopardize a mission’s success. Furthermore, the study found that even a year after returning to Earth, astronauts’ red blood cell destruction remained 30 percent higher than pre-flight levels. This suggests long-lasting changes to the body’s metabolic processes that require further investigation.
To compensate for the loss, the astronauts’ bodies were forced to produce more red blood cells to maintain a functional level. This requires a high-calorie, nutrient-dense diet rich in iron and protein to support the increased demand on the bone marrow. However, the researchers warn that simply increasing iron intake may not be the solution, as excessive iron can be toxic. The findings suggest that future spacecraft may need to be equipped with advanced hematology monitoring tools to track blood health in real-time during deep-space transit.
The research team is now looking into the specific mechanisms that trigger this increased destruction. They suspect that the lack of gravity affects the bone marrow’s ability to regulate cell lifespans or that the spleen becomes more aggressive in filtering out cells. Understanding these pathways is essential not only for astronauts but also for patients on Earth who suffer from anemia due to prolonged bed rest or chronic illness. By studying the extremes of space, hospital researchers are uncovering basic biological truths that could lead to new treatments for terrestrial blood disorders and improved recovery protocols for bedridden patients.

